Neuroone Medical Technologies (NMTC) Income towards Parent Company (2010 - 2026)

Neuroone Medical Technologies' Income towards Parent Company history runs 17 years deep, the most recent figure standing at -$2.4 million for Q1 2026.

• Quarterly Income towards Parent Company fell 4.91% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (down 5.1% YoY) and the FY2025 annual result came in at -$3.6 million, up 70.73% from the prior year.
• Income towards Parent Company was -$2.4 million for Q1 2026 at Neuroone Medical Technologies, down from -$1.4 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $1.8 million in Q4 2024 and bottomed at -$3.5 million in Q1 2023.
• A 5-year average of -$2.3 million and a median of -$2.8 million in 2022 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2024 — Income towards Parent Company surged 153.37% — and 2025, when it plunged 180.54%.
• Neuroone Medical Technologies' Income towards Parent Company stood at -$1.7 million in 2022, then plunged by 93.04% to -$3.3 million in 2023, then jumped by 153.37% to $1.8 million in 2024, then tumbled by 180.54% to -$1.4 million in 2025, then plunged by 65.66% to -$2.4 million in 2026.
• Business Quant data shows NMTC's Income towards Parent Company at -$2.4 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.6 million in Q3 2025.